PepsiCo (NASDAQ:PEP – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday. PEP has been the topic of several other research reports. Evercore upped their price objective on shares of PepsiCo from $165.00 […]

Insteel Industries (NYSE:IIIN – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday. Insteel Industries Stock Performance Shares of IIIN opened at $26.31 on Friday. The stock has a 50 day simple moving average of $34.68 and a […]

MongoDB (NASDAQ:MDB – Get Free Report) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Saturday. Several other analysts also recently issued reports on the company. Canaccord Genuity Group lowered their price target on MongoDB from $455.00 to $375.00 and set a […]

Bally’s (NYSE:BALY – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday. BALY has been the subject of a number of other reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Bally’s in a research note […]

Perma-Pipe International (NASDAQ:PPIH – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “strong-buy” rating to a “hold” rating in a report released on Saturday. Separately, Weiss Ratings raised shares of Perma-Pipe International from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, February […]

Crown (NYSE:CCK – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday. CCK has been the subject of a number of other research reports. Wolfe Research set a $115.00 price target on Crown in a […]

Avanos Medical (NYSE:AVNS – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday. Other equities research analysts also recently issued reports about the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Avanos Medical in […]

Pharvaris (NASDAQ:PHVS – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “strong sell” rating in a research note issued on Monday. Several other brokerages also recently weighed in on PHVS. Weiss Ratings restated a “sell (d-)” rating on shares of Pharvaris in a research […]

Element Solutions (NYSE:ESI – Get Free Report) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report issued on Sunday. A number of other brokerages have also recently issued reports on ESI. Truist Financial increased their target price on Element Solutions from $33.00 to $38.00 and […]

Latham Group (NASDAQ:SWIM – Get Free Report) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Sunday. A number of other equities analysts also recently issued reports on the company. William Blair reissued an “outperform” rating on shares of Latham Group in a research note […]

Nanovibronix (NASDAQ:FEED – Get Free Report) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Sunday. Separately, Weiss Ratings began coverage on Nanovibronix in a report on Tuesday, January 27th. They issued a “sell (e+)” rating on the stock. One research analyst has […]

Palvella Therapeutics (NASDAQ:PVLA – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday. A number of other research analysts also recently weighed in on PVLA. Chardan Capital raised their price objective on Palvella Therapeutics from $210.00 to […]

Meritage Homes (NYSE:MTH – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday. A number of other research analysts have also recently issued reports on MTH. The Goldman Sachs Group reaffirmed a “buy” rating and […]

AbbVie (NYSE:ABBV – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a report issued on Saturday. Other research analysts have also issued reports about the stock. William Blair reiterated an “outperform” rating on shares of AbbVie in a research note on Monday, March […]

Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Saturday. Other equities research analysts have also recently issued reports about the company. Sanford C. Bernstein decreased their price target on Regeneron Pharmaceuticals from $925.00 to $921.00 […]

IQVIA (NYSE:IQV – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday. A number of other equities research analysts have also issued reports on IQV. Weiss Ratings reiterated a “hold (c)” rating on shares of IQVIA in […]

Bristol Myers Squibb (NYSE:BMY – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Saturday. Several other research analysts also recently commented on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Bristol […]